T2 Biosystems (TTOO) Competitors $0.15 -0.01 (-8.26%) As of 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTOO vs. PAVM, CODX, ALUR, PSTV, MHUA, SSKN, POAI, NURO, INBS, and DHAIShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include PAVmed (PAVM), Co-Diagnostics (CODX), Allurion Technologies (ALUR), Plus Therapeutics (PSTV), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Predictive Oncology (POAI), NeuroMetrix (NURO), Intelligent Bio Solutions (INBS), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. PAVmed Co-Diagnostics Allurion Technologies Plus Therapeutics Meihua International Medical Technologies STRATA Skin Sciences Predictive Oncology NeuroMetrix Intelligent Bio Solutions DIH Holding US T2 Biosystems (NASDAQ:TTOO) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment. Does the MarketBeat Community favor TTOO or PAVM? T2 Biosystems received 202 more outperform votes than PAVmed when rated by MarketBeat users. However, 66.23% of users gave PAVmed an outperform vote while only 62.08% of users gave T2 Biosystems an outperform vote. CompanyUnderperformOutperformT2 BiosystemsOutperform Votes40662.08% Underperform Votes24837.92% PAVmedOutperform Votes20466.23% Underperform Votes10433.77% Is TTOO or PAVM more profitable? PAVmed has a net margin of 602.97% compared to T2 Biosystems' net margin of -563.16%. Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% PAVmed 602.97%N/A -92.36% Do insiders & institutionals have more ownership in TTOO or PAVM? 23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 19.9% of PAVmed shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by insiders. Comparatively, 7.3% of PAVmed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has better valuation & earnings, TTOO or PAVM? T2 Biosystems has higher revenue and earnings than PAVmed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.41-$50.08MN/AN/APAVmed$3.00M3.54-$64.18M$0.710.87 Which has more risk and volatility, TTOO or PAVM? T2 Biosystems has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, PAVmed has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Do analysts recommend TTOO or PAVM? T2 Biosystems presently has a consensus target price of $5.00, indicating a potential upside of 3,233.33%. PAVmed has a consensus target price of $19.50, indicating a potential upside of 3,045.16%. Given T2 Biosystems' higher probable upside, research analysts plainly believe T2 Biosystems is more favorable than PAVmed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer TTOO or PAVM? In the previous week, PAVmed had 7 more articles in the media than T2 Biosystems. MarketBeat recorded 7 mentions for PAVmed and 0 mentions for T2 Biosystems. PAVmed's average media sentiment score of 0.71 beat T2 Biosystems' score of 0.00 indicating that PAVmed is being referred to more favorably in the news media. Company Overall Sentiment T2 Biosystems Neutral PAVmed Positive SummaryPAVmed beats T2 Biosystems on 10 of the 15 factors compared between the two stocks. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.16M$4.54B$5.42B$8.48BDividend YieldN/A43.65%5.22%4.11%P/E RatioN/A29.8726.7820.05Price / Sales0.4170.45395.49116.44Price / CashN/A51.0838.2534.62Price / Book-0.026.346.874.61Net Income-$50.08M$67.64M$3.22B$248.19M7 Day Performance-10.66%21.94%5.69%2.56%1 Month Performance27.66%26.54%12.66%16.18%1 Year Performance-97.25%22.75%18.01%8.16% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 BiosystemsN/A$0.15-8.3%$5.00+3,233.3%-97.3%$3.16M$7.68M0.00180Analyst ForecastGap DownPAVMPAVmed4.1479 of 5 stars$0.71+3.6%$19.50+2,661.3%-65.6%$12.07M$3.00M-0.1690CODXCo-Diagnostics4.27 of 5 stars$0.34+0.5%$5.50+1,510.1%-75.0%$11.47M$3.92M-0.25100Gap UpALURAllurion Technologies3.5131 of 5 stars$2.38flat$22.83+859.4%-92.4%$11.41M$32.11M-0.20501Earnings ReportAnalyst RevisionPSTVPlus Therapeutics1.3933 of 5 stars$0.64-2.7%$11.50+1,691.6%-85.4%$10.91M$4.91M-0.2520Gap UpMHUAMeihua International Medical TechnologiesN/A$0.43+38.7%N/A-49.8%$10.78M$96.91M0.00620SSKNSTRATA Skin Sciences2.4992 of 5 stars$2.54+3.3%$6.00+136.2%-37.5%$10.59M$33.56M-0.95120Earnings ReportGap DownPOAIPredictive Oncology2.0719 of 5 stars$1.12+0.9%$3.00+167.9%-34.9%$10.00M$1.62M-0.3730News CoverageEarnings ReportGap UpNURONeuroMetrix0.1338 of 5 stars$4.55+4.4%N/A+14.3%$9.37M$3.03M-0.9920High Trading VolumeINBSIntelligent Bio Solutions0.4945 of 5 stars$1.25+2.9%N/A-47.8%$8.48M$3.03M0.0010Gap UpDHAIDIH Holding USN/A$0.17-3.9%N/A-85.4%$8.23M$64.47M-0.58N/AGap UpHigh Trading Volume Related Companies and Tools Related Companies PAVmed Competitors Co-Diagnostics Competitors Allurion Technologies Competitors Plus Therapeutics Competitors Meihua International Medical Technologies Competitors STRATA Skin Sciences Competitors Predictive Oncology Competitors NeuroMetrix Competitors Intelligent Bio Solutions Competitors DIH Holding US Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTOO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TTOO Stock Free TTOO Stock Alerts